For example, increased CD8+CD28+ T cells predict better early response to stereotactic ablative radiotherapy in non-small cell lung cancer and high frequency of PD-1+TIGIT+CD8+ T cells predict better response to anti-PD-1 therapy in melanoma and Merkel cell carcinoma. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.